thrombocytosi
usual
found
chanc
children
reactiv
secondari
thrombocytosi
common
form
infecti
diseas
preval
caus
regard
number
platelet
four
degre
thrombocytosi
extrem
degre
number
platelet
exce
describ
case
extrem
reactiv
thrombocytosi
healthi
child
requir
critic
care
admiss
diagnosi
treatment
maximum
number
platelet
review
differ
caus
thrombocytosi
childhood
differenti
diagnosi
avail
treatment
case
extrem
thrombocytosi
extrem
reactiv
thrombocytosi
healthi
yearold
child
de
plaqueta
de
se
revisan
la
diferent
causa
de
trombocitosi
en
la
infancia
se
describ
el
diferenci
se
discut
sobr
lo
diferent
tratamiento
dispon
ant
un
caso
como
el
descrito
cuidado
intensivo
trombocitosi
trombosi
trombocitosi
extrema
reactiva
en
un
sano
de
resumen
la
trombocitosi
es
un
hallazgo
casual
frecuent
en
en
predominan
la
forma
secundaria
siendo
la
infeccion
su
causa
prevalent
se
distinguen
grado
de
trombocitosi
en
del
de
plaqueta
en
la
forma
extrema
se
supera
el
se
presenta
un
caso
de
trombocitosi
extrema
reactiva
en
un
sano
de
que
ingreso
en
cuidado
intensivo
para
tratamiento
cifra
thrombocytosi
defin
platelet
count
two
standard
deviat
higher
upper
limit
normal
valu
l
frequent
found
chanc
paediatr
present
case
extrem
thrombocytosi
healthi
child
describ
treatment
differenti
diagnosi
complic
occur
evolut
admiss
hospit
boy
attend
emerg
depart
fever
day
cough
pain
left
side
asthenia
person
famili
histori
interest
gener
condit
fair
oxygen
satur
tachypnea
left
basal
hypoventil
oxygen
therapi
initi
nasal
cannula
follow
request
complet
blood
count
cbc
haemoglobin
gdl
white
blood
cell
neutrophil
platelet
b
coagul
test
normal
c
biochemistri
normal
creactiv
protein
mgdl
procalcitonin
ngml
chest
xray
left
basilar
infiltr
small
associ
effus
e
blood
cultur
presumpt
diagnosi
pneumonia
admit
oxygen
therapi
intraven
treatment
amoxicillinclavulan
acid
mgkgday
thrombocytosi
confirm
consid
possibl
reactiv
second
day
hospitalis
owe
increas
pleural
effus
patient
transfer
receiv
hospit
follow
anoth
chest
scan
watch
wait
approach
maintain
replac
amoxicillinclavulan
acid
intraven
cefotaxim
mgkgday
addit
new
cbc
perform
increas
thrombocytosi
observ
haemotolog
servic
consult
recommend
carri
diagnost
test
normal
red
blood
cell
morpholog
b
coagul
studi
protein
c
antithrombin
iii
c
autoimmun
antinuclear
antibodi
antineutrophil
cytoplasm
antibodi
perinuclear
antineutrophil
antibodi
rheumatoid
factor
serum
immunoglobin
immun
reconstitut
paraneoplast
phenomena
alphafoetoprotein
chorion
gonadotropin
third
day
hospitalis
ultrasound
scan
new
consolid
pleural
effus
found
right
lung
base
decid
modifi
treatment
wait
see
patient
evolv
fifth
day
hospitalis
patient
headach
sever
abdomin
pain
worsen
right
pleural
effus
increas
thrombocytosi
treatment
aspirin
mgkgday
initi
sinc
headach
abdomin
pain
consid
vasomotor
phenomena
clarithromycin
mgkgday
ad
treat
atyp
pathogen
supplementari
test
also
perform
neg
blood
test
chlamydophila
pneumonia
chlamydophila
psittaci
chlamydia
trachomati
coxiella
burnetii
influenza
viru
influenza
viru
b
polymeras
chain
reaction
pcr
adenoviru
mycoplasma
pneumonia
respiratori
syncyti
viru
c
francisella
tularensi
antibodi
legionella
pneumophila
serogroup
immunoglobin
igm
legionella
pneumophila
serogroup
cytomegaloviru
stool
cultur
adenoviru
rotaviru
faecal
parasit
e
hidden
blood
stool
faecal
calprotectin
f
echocardiogram
g
cranial
comput
tomographi
ct
normal
h
chest
abdomen
ct
pleural
effus
consolid
without
associ
mass
sixth
day
hospitalis
effus
drain
yield
ml
exud
pleural
fluid
adenosin
deaminas
indic
tuberculosi
detect
pneumococc
capsular
antigen
assay
binaxnow
neg
microorgan
gram
stain
neg
zielhneelsen
stain
pleural
fluid
analysi
also
includ
cultur
mycobacteria
fungi
bacteria
pcr
mycobacteria
anatom
patholog
examin
time
pleural
drainag
suction
biopsi
bone
marrow
carri
togeth
flexibl
fibr
optic
bronchoscopi
bronchoalveolar
lavag
bone
marrow
analysi
cultur
mycobacteria
fungi
bacteria
request
togeth
pcr
cytomegaloviru
epstein
barr
viru
addit
jak
ii
bcrabl
hybrid
genet
test
bronchoalveolar
lavag
analysi
includ
anatom
patholog
studi
cultur
mycobacteria
fungi
bacteria
immun
reconstitut
pcr
enteroviru
rhinoviru
coronaviru
parainfluenza
viru
influenza
b
c
virus
test
normal
neg
seventh
eighth
day
hospitalis
pleural
effus
fever
abdomin
pain
decreas
laboratori
valu
normalis
ninth
day
hospitalis
laboratori
test
perform
remov
drainag
increas
platelet
count
confirm
decid
carri
platelet
apheresi
avoid
possibl
thrombosi
right
femor
vein
cannul
purpos
platelet
count
success
reduc
tenth
day
hospitalis
patient
oedema
right
lower
extrem
partial
thrombosi
right
extern
iliac
vein
detect
low
molecular
weight
heparin
lmwh
start
h
twelfth
day
hospitalis
discharg
patient
remain
free
fever
headach
abdomin
pain
show
gradual
reduct
platelet
number
blood
flow
thrombos
area
normalis
day
discharg
treatment
aspirin
mgkgday
prophylact
dose
lmwh
test
perform
neg
normal
primari
caus
thrombocytosi
rule
consid
relat
respiratori
infect
aetiolog
diagnosi
caus
hospitalis
current
followup
haematolog
servic
platelet
count
normal
without
treatment
chanc
find
thrombocytosi
common
paediatr
must
alway
confirm
cbc
sinc
situat
give
rise
fals
increas
platelet
count
mix
cryoglobulinaemia
cellular
lysi
four
degre
thrombocytosi
describ
mild
moder
sever
extrem
massiv
aim
must
stabilis
treat
patient
determin
subsequ
whether
thrombocytosi
secondari
tabl
thorough
physic
examin
rule
presenc
visceromegali
adenopathi
soon
patient
admit
help
guid
diagnosi
differenti
diagnosi
must
made
stepbystep
base
patient
sign
symptom
diagnost
test
indic
provid
use
inform
appropri
risk
benefit
ratio
bear
mind
preval
caus
thrombocytosi
childhood
follow
test
could
consid
steril
bodi
fluid
cultur
blood
test
molecular
biolog
techniqu
e
assess
need
carri
suction
biopsi
bone
marrow
patient
remain
asymptomat
regardless
caus
thrombocytosi
high
platelet
count
associ
vasomotor
phenomena
headach
visual
symptom
nausea
chest
pain
dysaesthesia
aphasia
dysarthria
vertigo
instabl
shiver
erythromelalgia
thrombot
phenomena
haemorrhag
complic
tabl
vasomotor
phenomena
aris
intravascular
platelet
activ
normal
reactiv
thrombocytosi
entail
greater
risk
thromboembol
event
haemorrhag
complic
hand
primari
form
activ
symptomat
patient
patient
episod
headach
abdomin
pain
may
relat
extrem
thrombocytosi
start
treatment
controversi
aspirin
seem
suitabl
drug
suppress
thromboxan
product
lessen
platelet
activ
without
reduc
risk
thrombosi
clear
prophylact
anticoagul
lmwh
indic
even
extrem
thrombocytosi
count
asymptomat
children
initi
must
consid
individu
basi
patient
associ
prothrombot
factor
thalassaemia
reduct
protein
c
antithrombin
iii
presenc
central
venou
cathet
cytoreduct
therapi
kind
drug
platelet
apheresi
recommend
patient
low
risk
thrombosi
consid
symptom
prove
refractori
despit
appropri
treatment
tabl
case
aspirin
treatment
produc
modest
improv
patient
clinic
condit
platelet
apheresi
given
larg
number
platelet
state
activ
could
given
rise
thrombosi
extern
iliac
vein
sum
present
case
massiv
thrombocytosi
secondari
probabl
respiratori
infect
aim
must
treat
underli
infect
rule
primari
caus
thrombocytosi
apart
antimicrobi
drug
treatment
essenti
consist
support
measur
appear
vasomotor
phenomena
must
monitor
initi
aspirin
treatment
event
complic
bleed
thrombosi
acut
platelet
apheresi
carri
order
achiev
rapid
platelet
reduct
